| scholarly article | Q13442814 |
| P2093 | author name string | Daniel W Nebert | |
| Richard S Eisenstein | |||
| Glenn S Gerhard | |||
| Timothy P Dalton | |||
| Kerry L Ross | |||
| Jacqueline F Sinclair | |||
| Nadia Gorman | |||
| Peter R Sinclair | |||
| Heidi S Walton | |||
| Juliana G Szakacs | |||
| William J Bement | |||
| P2860 | cites work | Iron regulatory proteins and the molecular control of mammalian iron metabolism | Q28143426 |
| Inhibition of uroporphyrinogen decarboxylase by halogenated biphenyls in chick hepatocyte cultures. Essential role for induction of cytochrome P-448 | Q28366673 | ||
| A mouse model of familial porphyria cutanea tarda | Q28507743 | ||
| Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism | Q28510829 | ||
| Uroporphyria in Hfe mutant mice given 5-aminolevulinate: a new model of Fe-mediated porphyria cutanea tarda | Q31921576 | ||
| Human drug-metabolizing enzyme polymorphisms: effects on risk of toxicity and cancer | Q40992263 | ||
| Iron Deficiency Prevents Liver Toxicity of 2,3,7,8-Tetrachlorodibenzo- p -Dioxin | Q41521465 | ||
| Porphyria Cutanea Tarda of the Toxic and Sporadic Varieties | Q41745505 | ||
| Inhibition of uroporphyrinogen decarboxylase activity. The role of cytochrome P-450-mediated uroporphyrinogen oxidation | Q41868201 | ||
| Synergism of iron and hexachlorobenzene inhibits hepatic uroporphyrinogen decarboxylase in inbred mice | Q41938430 | ||
| Genetic variation of iron-induced uroporphyria in mice | Q41969993 | ||
| Uroporphyria induced by 5-aminolaevulinic acid alone in Ahrd SWR mice | Q42527457 | ||
| Ascorbic acid deficiency in porphyria cutanea tarda | Q42547915 | ||
| Porphyria cutanea tarda, hepatitis C, and HFE gene mutations in north america† | Q42988426 | ||
| Protection of the Cyp1a2(-/-) null mouse against uroporphyria and hepatic injury following exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin | Q43624937 | ||
| Multiple Roles of Polyhalogenated Biphenyls in Causing Increases in Cytochrome P450 and Uroporphyrin Accumulation in Cultured Hepatocytes | Q48771416 | ||
| Chlorinated biphenyls induce cytochrome P450IA2 and uroporphyrin accumulation in cultures of mouse hepatocytes | Q54317196 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 912-921 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | Hepatology | Q15724398 |
| P1476 | title | Uroporphyria in mice: thresholds for hepatic CYP1A2 and iron | |
| P478 | volume | 35 |
| Q24681370 | A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda |
| Q41730972 | Activity of cytochrome P450 1A2 in relation to hepatic iron accumulation in transfusion-dependent β-thalassaemia major patients |
| Q84587889 | Attenuation of polychlorinated biphenyl induced uroporphyria by iron deprivation |
| Q24815975 | Biomarker measurements in a coastal fish-eating population environmentally exposed to organochlorines |
| Q81247403 | Effect of an oral iron chelator or iron-deficient diets on uroporphyria in a murine model of porphyria cutanea tarda |
| Q79449900 | Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda |
| Q44557689 | Export of a heterologous cytochrome P450 (CYP105D1) in Escherichia coli is associated with periplasmic accumulation of uroporphyrin |
| Q28586157 | For dioxin-induced birth defects, mouse or human CYP1A2 in maternal liver protects whereas mouse CYP1A1 and CYP1B1 are inconsequential |
| Q45070103 | Genetic factors influence ethanol-induced uroporphyria in Hfe(-/-) mice |
| Q35212534 | Iron as a co-morbid factor in nonhemochromatotic liver disease |
| Q36871056 | Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs |
| Q39345761 | Uroporphyria in the Cyp1a2-/- mouse |
| Q44301824 | Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda |
Search more.